Acharya Gagandeep, Kaushik Rajeev Mohan, Gupta Rohit, Kaushik Reshma
Department of General Medicine, Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, India.
Inflamm Intest Dis. 2020 Feb;5(1):1-10. doi: 10.1159/000503921. Epub 2019 Nov 8.
Child-Turcotte-Pugh (CTP), Model for End-Stage Liver Disease (MELD) and MELD-sodium (MELD-Na) scores are used for predicting disease severity and mortality among patients with end-stage liver disease. However, data regarding their usefulness in predicting the short-term outcome of end-stage liver disease are not available in India. This prospective study compared the CTP score, MELD score and MELD-Na score as predictors of short-term outcome among patients with end-stage liver disease.
CTP, MELD and MELD-Na scores were determined in 171 patients with end-stage liver disease at a tertiary healthcare centre in India at the time of admission, and the concordance (C-) statistics of the three scores for 3-month mortality were assessed and compared. The aetiology of end-stage liver disease and the clinical presentation were determined.
The CTP score, MELD score and MELD-Na score on day 1 were significantly higher among non-survivors than among survivors ( < 0.0001 each). The C-statistic for 3-month mortality for the CTP score was 0.93 ( < 0.0001), that for the MELD score was 0.86 ( < 0.0001) and that for the MELD-Na score was 0.83 ( < 0.0001). The C-statistics of these scores differed significantly for 3-month mortality, and the CTP score was better than the MELD ( < 0.0001) and MELD-Na ( < 0.0001) scores in predicting 3-month mortality.
The CTP, MELD and MELD-Na scores were very good predictors of mortality at 3 months among patients with end-stage liver disease. The CTP score was superior to the MELD and MELD-Na scores in predicting 3-month mortality.
儿童-托考特-普格(CTP)评分、终末期肝病模型(MELD)评分和MELD-钠(MELD-Na)评分用于预测终末期肝病患者的疾病严重程度和死亡率。然而,在印度,关于它们在预测终末期肝病短期预后方面有用性的数据尚不可得。这项前瞻性研究比较了CTP评分、MELD评分和MELD-Na评分作为终末期肝病患者短期预后的预测指标。
在印度一家三级医疗中心,对171例终末期肝病患者入院时测定CTP、MELD和MELD-Na评分,并评估和比较这三个评分对3个月死亡率的一致性(C-)统计量。确定终末期肝病的病因和临床表现。
非幸存者第1天的CTP评分、MELD评分和MELD-Na评分显著高于幸存者(均P<0.0001)。CTP评分对3个月死亡率的C统计量为0.93(P<0.0001),MELD评分为0.86(P<0.0001),MELD-Na评分为0.83(P<0.0001)。这些评分对3个月死亡率的C统计量有显著差异,CTP评分在预测3个月死亡率方面优于MELD评分(P<0.0001)和MELD-Na评分(P<0.0001)。
CTP、MELD和MELD-Na评分是终末期肝病患者3个月死亡率的良好预测指标。CTP评分在预测3个月死亡率方面优于MELD评分和MELD-Na评分。